11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease Anna AndersonBrian R. Walker Leading Article 29 August 2013 Pages: 1385 - 1393
The Optimal Management of Follicular Lymphoma: An Evolving Field Chaitra UjjaniBruce D. Cheson Therapy in Practice 25 July 2013 Pages: 1395 - 1403
Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease Susan H. Fox Review Article 06 August 2013 Pages: 1405 - 1415
Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer Rana R. McKayToni K. ChoueiriMary-Ellen Taplin Review Article 13 August 2013 Pages: 1417 - 1430
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy Giovanni GuaraldiChiara StentarelliAntonella Santoro Review Article 04 September 2013 Pages: 1431 - 1450
Eplerenone: A Review of Its Use in Patients with Chronic Systolic Heart Failure and Mild Symptoms Sohita Dhillon Adis Drug Evaluation 24 July 2013 Pages: 1451 - 1462
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis Paul L. McCormack Adis Drug Evaluation 03 August 2013 Pages: 1463 - 1481
Sumatriptan Iontophoretic Transdermal System: A Review of Its Use in Patients with Acute Migraine Karly P. Garnock-Jones Adis Drug Evaluation 03 August 2013 Pages: 1483 - 1490
Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer Paul L. McCormack Adis Drug Evaluation 28 August 2013 Pages: 1491 - 1502
Afatinib: First Global Approval Rosselle T. DungoGillian M. Keating R&D Insight Report 28 August 2013 Pages: 1503 - 1515